Neogenomics Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NEO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

350,847

Value ($000)

4,126

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,126	0.0%	350,847	12/31/2025
2025 Q3	11/14/2025	2,727	0.0%	353,258	9/30/2025
2025 Q2	8/14/2025	4,253	0.0%	581,787	6/30/2025
2025 Q1	5/19/2025	4,721	0.0%	497,451	3/31/2025
2024 Q4	2/14/2025	10,648	0.0%	646,111	12/31/2024
2024 Q3	11/14/2024	8,897	0.0%	603,216	9/30/2024
2024 Q2	8/14/2024	8,689	0.0%	626,455	6/30/2024
2024 Q1	5/15/2024	6,618	0.0%	421,019	3/31/2024
2023 Q4	2/14/2024	6,533	0.0%	403,752	12/31/2023
2023 Q3	11/13/2023	5,135	0.0%	417,486	9/30/2023
2023 Q2	8/11/2023	6,885	0.0%	395,465	6/30/2023
2023 Q1	5/15/2023	6,885	0.0%	395,465	3/31/2023
2022 Q3	11/14/2022	3,254	0.0%	377,967	9/30/2022
2022 Q2	8/12/2022	3,351	0.0%	411,173	6/30/2022
2022 Q1	5/16/2022	5,157	0.0%	424,422	3/31/2022
2021 Q4	2/14/2022	14,656	0.0%	429,542	12/31/2021
2021 Q3	11/15/2021	21,134	0.0%	438,096	9/30/2021
2021 Q2	8/16/2021	20,254	0.0%	448,401	6/30/2021
2021 Q1	5/14/2021	22,197	0.0%	460,241	3/31/2021
2020 Q4	3/1/2021	24,501	0.0%	455,072	12/31/2020
2020 Q3	11/13/2020	17,263	0.0%	467,962	9/30/2020
2020 Q2	8/14/2020	14,421	0.0%	465,504	6/30/2020
2020 Q1	5/15/2020	12,349	0.0%	447,248	3/31/2020
2019 Q4	2/14/2020	2,823	0.0%	96,526	12/31/2019